References
- Watson CP, Oaklander AL. Postherpetic neuralgia. Pain Pract 2002;2:295-307
- Gialloreti L, Merito M, Pezzotti P, et al. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis 2010;10:230
- Johnson RW, McElhaney J. Postherpetic neuralgia in the elderly. Int J Clin Pract 2009;63:1386-91
- Weinke T, Edte A, Schmitt S, Lukas K. Impact of herpes zoster and post-herpetic neuralgia on patients’ quality of life: a patient-reported outcomes survey. Z Gesundh Wiss 2010;18:367-74
- Baron R, Mayoral V, Leijon G, et al. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial. Clin Drug Investig 2009;29:231-41
- Binder A, Bruxelle J, Rogers P, et al. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial. Clin Drug Investig 2009;29:393-408
- Hans G, Sabatowski R, Binder A, et al. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study. Curr Med Res Opin 2009;25:1295-305
- Katz N, Gammaitoni A, Davis M, Dworkin R. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial. Pain Med 2002;3:324-32
- Kern K, Kohl M, Kiefer RT. Lidocain-Pflaster zur Therapie neuropathischer und nichtneuropathischer Schmerzen. Klinische Fallstudie an 87 Patienten. Nervenarzt 2010;81:1490-7
- Lin P, Fan S, Huang C, et al. Analgesic effect of lidocaine patch 5% in the treatment of acute herpes zoster: a double-blind and vehicle-controlled study. Reg Anesth Pain Med 2008;33:320-5
- Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 2003;106:151-8
- Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65:39-44
- Krumova E, Zeller M, Westermann A, Maier C. Lidocaine patch (5%) produces a selective, but incomplete block of Adelta and C fibers. Pain 2012;153:273-80
- Wolff RF, Bala MM, Westwood M, et al. 5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review. Acta Neurol Scand 2011;123:295-309
- Dworkin R, O’Connor A, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010;85:S3-14
- Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010;17:1113-e88
- Finnerup N, Sindrup S, Jensen T. Recent advances in pharmacological treatment of neuropathic pain. F1000 Med Rep 2010;2:52
- Edwards IR, Biriell C. Harmonisation in pharmacovigilance. Drug Saf 1994;10:93-102
- Grzanka A, Misiolek H, Filipowska A, et al. Adverse effects of local anaesthetics – allergy, toxic reactions or hypersensitivity. Anestezjol Intens Ter 2010;42:175-8
- Versatis 5% Medicated Plaster – Summary of Product Characteristics (SPC) – electronic Medicines Compendium (eMC). Available at: http://www.medicines.org.uk/emc/medicine/19291 [Last accessed 24 April 2012]
- Kallio H, Niskanen ML, Havia M, et al. I.V. ropivacaine compared with lidocaine for the treatment of tinnitus. Br J Anaesth 2008;101:261-5
- Jurgens G, Graudal N, Kampmann J. Therapeutic drug monitoring of antiarrhythmic drugs. Clin Pharmacokinet 2003;42:647-63
- Rehm S, Binder A, Baron R. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study. Curr Med Res Opin 2010;26:1607-19
- Garnock-Jones K, Keating G. Lidocaine 5% medicated plaster: a review of its use in postherpetic neuralgia. Drugs 2009;69:2149-65
- Galer B, Gammaitoni A. More than 7 years of consistent neuropathic pain relief in geriatric patients. Arch Intern Med 2003;163:628
- Wilhelm I, Tzabazis A, Likar R, et al. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster. Eur J Anaesthesiol 2011;27:169-73